Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2005
08/09/2005US6927280 Cocoa albumin and its use in the production of cocoa and chocolate flavor
08/09/2005US6927278 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals
08/09/2005US6927236 For therapy of degenerative neuropathy, Alzheimer's disease
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927208 for the treatment and prevention of AIDS
08/09/2005US6927207 polypeptides; cell recognition molecule which couples to the polypeptide, wherein the cell recognition molecule selectively binds to target cells; antitumor agents; used for example as a prophylactic against relapse after surgical tumour removal
08/09/2005US6927206 treating dermatological conditions related to rosacea by topically applying a composition comprising at least one peptide copper complex to an area of affected skin
08/09/2005US6927205 Compositions and methods for treatment of psoriasis
08/09/2005US6927204 Increasing the number of inner ear hair cells, by administering insulin-like growth factor-1 and/or fibroblast growth factor-2, or their agonists
08/09/2005US6927203 Treatment of metastatic disease
08/09/2005US6927044 IL-1 receptor based cytokine traps
08/09/2005US6927043 Cancer therapy
08/09/2005US6927042 Glycoprotein synthesis
08/09/2005US6927041 Human neuropeptide Y-like G protein-coupled receptor
08/09/2005US6926910 Hydrophobe biomolecular structure
08/09/2005US6926908 Formulation for inhalation
08/09/2005US6926899 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926896 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction
08/09/2005US6926894 For the prophylaxis or therapy of thrombosis and thromboembolic diseases
08/09/2005US6926893 Multi-stage cascade boosting vaccine
08/09/2005US6926888 producer cell ( encapsulated in a matrix which containing alginates) containing a plasmid that includes a nucleic acid sequence that encodes endostatin, angiostatin, thrombospondin, or prolactin
08/09/2005US6926884 GPIb-lipid bond construct and use thereof
08/09/2005CA2168012C Polymeric matrices and their uses in pharmaceutical compositions
08/09/2005CA2150346C Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody
08/09/2005CA2136952C Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-– and histamine, serotonin, amines or substances with corresponding receptor activity
08/09/2005CA2135278C Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
08/09/2005CA2109098C Activity-dependent neurotrophic factor
08/09/2005CA2019676C Particle-mediated transformation of animal somatic cells
08/04/2005WO2005071093A2 Chimpanzee adenovirus vaccine carriers
08/04/2005WO2005071084A1 Construction of gutted recombinant adenovirus effectively expressing antibodies comprising human constant region and uses thereof
08/04/2005WO2005071080A2 Modulation of glucocorticoid receptor expression
08/04/2005WO2005071075A1 Peptide originating in epidermal growth factor receptor (egfr)
08/04/2005WO2005071073A1 Fap compositions and the use thereof for immunomodulation
08/04/2005WO2005071071A1 Ptd-human choline acetyltransferase fusion protein and its application
08/04/2005WO2005071070A2 Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors
08/04/2005WO2005070955A1 Macrocyclic peptides active against the hepatitis c virus
08/04/2005WO2005070480A1 Apparatus and methods for enzymatic debridement of skin lesions
08/04/2005WO2005070468A2 Transglutaminase mediated conjugation of peptides
08/04/2005WO2005070451A1 Pharmaceutical composition comprising non-glycosylated erythropoietin
08/04/2005WO2005070450A2 Use of low-dose erythropoietin for the treatment of acute or chronic kidney failure and for the treatment of wounds
08/04/2005WO2005070449A1 Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
08/04/2005WO2005070448A2 Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
08/04/2005WO2005070447A2 M-csf muteins and uses thereof
08/04/2005WO2005070446A1 Method for treating cardiac remodeling following myocardial injury
08/04/2005WO2005070445A2 Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
08/04/2005WO2005070444A2 Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
08/04/2005WO2005070439A1 Implant comprising a human muscle tissue matrix
08/04/2005WO2005070415A1 Adjuvant compositions
08/04/2005WO2005070409A1 A method of modulating pro-inflammatory and inflammatory activity mediated by c-reactive protein
08/04/2005WO2005070394A2 Ternary non-lamellar lipid compositions
08/04/2005WO2005070328A1 Muscle-based grafts/implants
08/04/2005WO2005070148A2 Methods of using high affinity atiii variants
08/04/2005WO2005070138A2 O-linked glycosylation of peptides
08/04/2005WO2005069975A2 Lysyl oxidase-like 1 (loxl1) and elastogenesis
08/04/2005WO2005069888A2 Smac peptidomimetics and the uses thereof
08/04/2005WO2005069854A2 Methods and materials relating to novel c1q domain-containing polypeptides and polynucleotides
08/04/2005WO2005069758A2 Frequency assisted transdermal agent delivery method and system
08/04/2005WO2005061532A8 Pathogenic infection detection compositions and methods
08/04/2005WO2005059131A3 Protein binding miniature proteins and uses thereof
08/04/2005WO2005058889A3 Biological active blood serum obtained by electrostimulation
08/04/2005WO2005054426A3 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
08/04/2005WO2005052001A3 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
08/04/2005WO2005051990A3 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer
08/04/2005WO2005048930A3 Surfactant-based gel as an injectable, sustained drug delivery vehicle
08/04/2005WO2005047319A3 Dna sequence and expressed recombinant glycoproteins related to feline thyrotropin
08/04/2005WO2005037865A3 Ztnfr14, A TUMOR NECROSIS FACTOR RECEPTOR
08/04/2005WO2005027827A3 Host defense factor x (hdfx)
08/04/2005WO2005024040A3 Target and method for inhibition of bacterial rna polymerase: minimized derivatives of peptide antibiotic mccj25
08/04/2005WO2005021579A3 Epo mimetic peptides and fusion proteins
08/04/2005WO2005019471A3 Periostin-like factor: compositions and methods for making and using the same
08/04/2005WO2005003350A3 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER’S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/04/2005WO2005002516A3 Leukocyte internalized peptide-drug conjugates
08/04/2005WO2005000236A3 Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
08/04/2005WO2004093807A3 Somatostatin vectors
08/04/2005WO2004092360A3 The severe acute respiratory syndrome coronavirus
08/04/2005WO2004089283A3 Compositions and methods for treating viral infections
08/04/2005WO2004083234A3 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
08/04/2005WO2004082578A3 Use of soluble cd14 for treatment of diseases
08/04/2005WO2004073651A3 Identifying inhibitors of intracellular protein fibrillization
08/04/2005WO2004072240A3 Antiplasmin cleaving enzyme
08/04/2005WO2004066966A3 Peptide yy analogs
08/04/2005WO2004060908A3 Method to increase fibronectin
08/04/2005WO2004060275A3 Wound care compositions
08/04/2005WO2004055158A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/04/2005WO2004046324A3 Allele-targeted rna interference
08/04/2005WO2004046309A3 Methods for inhibiting viral replication in vivo
08/04/2005WO2004046165A3 Treatment of ophthalmic conditions with kpv and kpv dimers
08/04/2005WO2004030750A8 Antisense modulation of farnesoid x receptor expression
08/04/2005WO2004020608A3 Modulators of tnf-alpha and il-1 cell surface receptor activity
08/04/2005WO2004016726A9 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/04/2005WO2004005316A3 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
08/04/2005WO2004004658A3 Methods and compositions relating to isoleucine boroproline compounds
08/04/2005WO2003064589A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/04/2005WO2003000009A3 Stimulation of vascularization with vegf-b
08/04/2005US20050172359 Using expression vector comprising phaseolin promoter to transfer and express plasma lipoprotein in seeds
08/04/2005US20050172356 Expression vector comprising nucleotide sequences coding chimeric insecticidal/vacuole targeting protein for use in biological pest control; insect resistance in crop plants
08/04/2005US20050172353 Expression vector for improving heterologous gene expression; herbicide resistant crop plants
08/04/2005US20050172352 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/04/2005US20050172346 Method for treating a condition with a SOCS-3 promoter linked to a polynucleotide encoding SOCS-3
1 ... 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 ... 3163